27. Serwacka A, Protaziuk T, Zagozda M, et al. Lack of effect of the CD14 promoter gene C-159T polymorphism on nutritional status parameters in hemodialysis patients. Med Sci Monit 2011; 17: CR117-21. 28. Stefano GB, Kream RM, Esch T. Revisiting tolerance from the endogenous morphine perspective. Med Sci Monit 2009; 15: RA189-98. 29. Vithoulkas G, Carlino S. The “continuum” of a unified theory of diseases. Med Sci Monit 2010; 16: SR7-15. 30. Weeks BS, Perez PP. The hemicellulose preparation, Natramune (PDS-2865), increases macrophage phagocytosis and nitric oxide production and increases circulating human lymphocytes levels. Med Sci Monit 2009; 15: BR43-6. 31. Romanowska M, Banaszkiewicz A, Nowak I, Radzikow- ski A, Brydak LB. Immunization against influenza during the 2005/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD). Med Sci Monit 2010; 16: CR433-9. 32. Gong YB, Huang YF, Li Y, et al. Experimental study of the mechanism of tolerance induction in dexamethasone- treated dendritic cells. Med Sci Monit 2011; 17: BR125-31. 33. Kubisz P, Plamenova I, Holly P, Stasko J. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy. Med Sci Monit 2009; 15: CS105-11. 34. Hossny E, El-Awady H, El-Feky M, El-Owaidy R. Screening for B- and T-cell defects in Egyptian infants and children with suspected primary immunodeficiency. Med Sci Monit 2009; 15: CR217-25. 35. Lu JM, Nurko J, Weakley SM, et al. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit 2010; 16: RA93-100. 36. Ge P, Zhang P, Wang H, Zhong Y, Luo Y. Ischemic post- conditioning: a feasible preventive method for cerebral hyperperfusion syndrome secondary to revascularization. Med Sci Monit 2010; 16: SC9-11. 37. Rafael H. Revascularization in some neurodegenerative diseases. Med Sci Monit 2009; 15: LE5-6. 38. Park DH, Eve DJ, Borlongan CV, Klasko SK, Cruz LE, Sanberg PR. From the basics to application of cell therapy, a steppingstone to the conquest of neurodegeneration: a meeting report. Med Sci Monit 2009; 15: RA23-31. 39. Rafael H. Cerebral atherosclerosis causes neuro- degenerative diseases. Med Sci Monit 2010; 16: LE1-2. 40. Alberti E, Los M, Garcia R, et al. Prolonged survival and expression of neural markers by bone marrow-derived stem cells transplanted into brain lesions. Med Sci Monit 2009; 15: BR47-54. 41. Gross S, Homan van der Heide JJ, van Son WJ, et al. Body mass index and creatinine clearance are associated with steady-state serum concentrations of the cell damage marker S100B in renal transplant recipients. Med Sci Monit 2010; 16: CR318-24. 42. Brucknerova I, Behulova D, Bzduch V, Mach M, Dubovicky M, Ujhazy E. Newborn with neonatal form of molybdenum cofactor deficiency – the first patient in the Slovak Republic. Neuro Endocrinol Lett 2010; 31 Suppl 2: 5-7. 43. Bik W, Ostrowski J, Baranowska-Bik A, et al. Adipokines and genetic factors in overweight or obese but metabolically healthy Polish women. Neuro Endocrinol Lett 2010; 31: 497-506. Neuroimmune-vascular cells and their pathological disorders 44. Bik W, Baranowska B. Adiponectin – a predictor of higher mortality in cardiovascular disease or a factor contributing to longer life? Neuro Endocrinol Lett 2009; 30: 180-4. 45. Chmielowska M, Baranowska-Bik A, Baranowska B, Wolinska-Witort E, Martynska L, Bik W. The influence of cocaine-amphetamine regulated transcript (CART) on pituitary hormones, corticosterone and leptin levels in starved rats. Neuro Endocrinol Lett 2011; 32: 82-9. 46. Erren TC, Falaturi P, Reiter RJ. Research into the chronodisruption-cancer theory: the imperative for causal clarification and the danger of causal reductionism. Neuro Endocrinol Lett 2010; 31: 1-3. 47. Kochman K, Gajewska A, Bieniarz K. Differential binding of mammalian and salmon GnRHs with rat and carp pituitary receptors. Neuro Endocrinol Lett 2009; 30: 139-43. 48. Pisarek H, Kunert-Radek J, Radek M, Swietoslawski J, Winczyk K, Pawlikowski M. Expression of somatostatin receptor subtypes in primary and recurrent gonado- tropinomas: are somatostatin receptors involved in pituitary adenoma recurrence? Neuro Endocrinol Lett 2011; 32: 96-101. 49. Wasilewska-Dziubinska E, Gajewska A, Wolinska-Witort E, et al. Valproate inhibits GnRH-induced gonadotropin release from anterior pituitary cells of male rat in vitro. Neuro Endocrinol Lett 2011; 32: 206-11. 50. Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Lawnicka H, Pawlikowski M. Effects of rosiglitazone: peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro. Neuro Endocrinol Lett 2009; 30: 107-10. 51. Ondicova K, Pecenak J, Mravec B. The role of the vagus nerve in depression. Neuro Endocrinol Lett 2010; 31: 602-8. 52. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways. Neuro Endocrinol Lett 2011; 32: 7-24. 53. Erren TC, Reiter RJ. Axelrod, the pineal and the melatonin hypothesis: lessons of 50 years to shape chronodisruption research. Neuro Endocrinol Lett 2010; 31: 585-7. 54. Kelemenova S, Ostatnikova D. Neuroendocrine pathways altered in autism. Special role of reelin. Neuro Endocrinol Lett 2009; 30: 429-36. 55. Sieroslawska A, Rymuszka A. Cyanohepatotoxins influence on the neuroendocrine and immune systems in fish – a short review. Neuro Endocrinol Lett 2009; 30 Suppl 1: 13-6. Arch Med Sci 5, October / 2011 743